将血脂控制在合理适当水平是降低冠心病发病率和死亡率的重要措施,也是当前心血管病领域重主要任之一。近年,提出了许多新的非药物治疗循证医学证据和新资料,我们收集梳理,结合我国现状探讨血脂异常非药物综合干预措施,供同行参考。1纠正血脂异常意义重大全球每年约有近1700万人死于心血管疾病,居首位。其中最大比例是冠心病,其基本病理是动脉粥样硬化(AS)。基础 To control blood lipids at a reasonable and appropriate level is to reduce the incidence of coronary heart disease and mortality an important measure, but also one of the major areas of the current cardiovascular disease. In recent years, many new non-drug evidence-based medical treatment and new data have been put forward. Combining with the current situation in our country, we explore the non-drug comprehensive interventions for dyslipidemia for peer reference. 1 to correct the significance of dyslipidemia Significant global annual about 1700 million people died of cardiovascular disease, ranking first. The largest proportion of them is coronary heart disease, the basic pathology is atherosclerosis (AS). basis